Roman Franklin
Equibles does not estimate personal net worth.
Get an email with a short summary when Vivos Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get VVOS alertsAbout Roman Franklin
Roman Franklin is recorded as CFO at Vivos Therapeutics, Inc. (VVOS) since July 31, 2026. Vivos Therapeutics, Inc. reported in an 8-K filed August 3, 2026 that Roman Franklin was appointed Chief Financial Officer and Principal Financial Officer. Vivos Therapeutics, Inc. reported in an 8-K filed August 3, 2026 that Roman Franklin was appointed Chief Financial Officer, effective July 31, 2026. Vivos Therapeutics, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Vivos Therapeutics, Inc. includes R. Kirk Huntsman (CEO), Anja Krammer (Board Member), Gregg C. E. Johnson (Board Member) and 4 others.
“Effective on the Effective Date, Client shall appoint the Engagement Lead (Roman Franklin) as Client’s Chief Financial Officer (“CFO”) and Principal Financial Officer (“PFO,” and together with the CFO title, the “CFO/PFO”) for purposes of the Securities Exchange Act of 1934, the Sarbanes-Oxley Act of 2002, and applicable Nasdaq listing rules.”
“Effective July 31, 2026, the Board appointed Roman Franklin, age 42, as the Company's Chief Financial Officer, and designated Mr. Franklin as the Company's principal financial officer for purposes of the Securities Exchange Act of 1934, as amended.”
Affiliation history
-
Current
2026-07-31–present
Company network
Leadership on record at Vivos Therapeutics, Inc.
- R. Kirk Huntsman CEO
- Anja Krammer Board Member
- Gregg C. E. Johnson Board Member
- Leonard J. Sokolow Board Member
- Mark F. Lindsay Board Member
- Matthew Thompson Board Member
- Ralph E. Green Board Member